NRG HN003 Cisplatin, Intensity Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma

June 29, 2018
https://clinicaltrials.gov/ct2/show/NCT02775812
Cancer - Head and Neck
Principal Investigator: Ding Wang, MD
CANCER, HEAD, NECK, STAGE 3, STAGE 4, SQUAMOUS CELL, HEAD CANCER, NECK CANCER
Open